Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Siân Jones(Howard Hughes Medical Institute), Kenneth W. Kinzler(Johns Hopkins University), Victor E. Velculescu(Johns Hopkins University), Parminder K. Mankoo(Johns Hopkins University), Hannah Carter(Johns Hopkins University), Philipp Angenendt(Howard Hughes Medical Institute), Kimberly Walter(Johns Hopkins University), Rebecca Leary(Howard Hughes Medical Institute), James Hartigan(Johns Hopkins University), Steven D. Leach(Dartmouth College), Alison P. Klein(Johns Hopkins University), Rachel Karchin(University of Baltimore), Nickolas Papadopoulos(Johns Hopkins University), D. Williams Parsons(Baylor College of Medicine), Christine A. Iacobuzio–Donahue(Johns Hopkins University), Anirban Maitra(NYU Langone Health), Elizabeth M. Jaffee(Bloomberg (United States)), Giovanni Parmigiani(Harvard University Press), Mihoko Kamiyama(Johns Hopkins University), James R. Eshleman(Johns Hopkins University), Hirohiko Kamiyama(Johns Hopkins University), Seung‐Mo Hong(Ulsan College), Yuri Nikolsky(Johns Hopkins University), Bert Vogelstein(Johns Hopkins University), Eric S. Calhoun(Johns Hopkins University), Manuel Hidalgo(Hospital Universitario de Fuenlabrada), Michael Goggins(Johns Hopkins University), Ming‐Tseh Lin(Johns Hopkins University), Douglas R. Smith(Johns Hopkins University), Antonio Jimeno(The Medical Center of Aurora), Scott E. Kern(Johns Hopkins University), Tatiana Nikolskaya(Russian Academy of Sciences), Baojin Fu(Johns Hopkins University), Jimmy Lin(Johns Hopkins University), Ralph H. Hruban(Johns Hopkins University)
Cited by 4,040
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k